Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson beats in Q2; raises FY guidance

Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2 sales of $23.3 billion, up 27% year-over-year and higher than the Wall Street projection. Net income of $2.48 per share was also above the target that analysts had anticipated.

JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.

 johnson & Johnson Q2 2021 earnings

Looking forward to listening to management/analyst comments on the results? Stay tuned here for Johnson & Johnson Q2 earnings call transcript

Prior performance

  • Johnson & Johnson Q4 2020 earnings
  • Johnson & Johnson Q3 2020 earnings
  • Johnson and Johnson reports Q2 2020 earnings results

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top